S
Silvio Danese
Researcher at Catholic University of the Sacred Heart
Publications - 8
Citations - 569
Silvio Danese is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Ulcerative colitis & Proctocolectomy. The author has an hindex of 6, co-authored 8 publications receiving 541 citations.
Papers
More filters
Journal ArticleDOI
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
Gert Van Assche,Axel Dignass,Bernd Bokemeyer,Silvio Danese,Paolo Gionchetti,Gabriele Moser,Laurent Beaugerie,Fernando Gomollón,Winfried Häuser,Klaus Herrlinger,Bas Oldenburg,Julián Panés,Francisco Portela,Gerhard Rogler,Jürgen Stein,Herbert Tilg,Simon Travis,James O. Lindsay +17 more
TL;DR: Pouchitis is a non-specific inflammation of the ileal reservoir and the most common complication of IPAA in patients with UC, and may be caused by conditions other than pouchitis, including Crohn's disease of the pouch and an irritable pouch.
Journal ArticleDOI
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
Gert Van Assche,Axel Dignass,Bernd Bokemeyer,Silvio Danese,Paolo Gionchetti,Gabriele Moser,Laurent Beaugerie,Fernando Gomollón,Winfried Häuser,Klaus Herrlinger,Bas Oldenburg,Julián Panés,Francisco Portela,Gerhard Rogler,Jürgen Stein,Herbert Tilg,Simon Travis,James O. Lindsay +17 more
TL;DR: Pouchitis is a non-specific inflammation of the ileal reservoir and the most common complication of proctocolectomy in patients with ulcerative colitis as discussed by the authors.
Journal ArticleDOI
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?
TL;DR: Improvement in the design and specificity of clinical studies are mandatory to be able to classify tissue markers as predictors of disease course and response to specific therapy, obtain the goal of achieving "personalized pathogenesis-oriented therapy" in IBD.
Journal ArticleDOI
Increased expression of CD133 is a strong predictor of poor outcome in stage i colorectal cancer patients
Luca Reggiani Bonetti,Mario Migaldi,Emanuele Caredda,Alma Boninsegna,Maurizio Ponz de Leon,Carmela Di Gregorio,Valeria Barresi,D. Scannone,Silvio Danese,Achille Cittadini,Alessandro Sgambato +10 more
TL;DR: It is demonstrated that CD133 immunostaining is a useful predictor of high risk progression in stage I CRC patients and might help to identify patients eligible for adjuvant chemotherapy.